Skip to main content

In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.

Publication ,  Journal Article
Green, M; Allen, C; Bradley, J; Dashefsky, B; Gilsdorf, JR; Marcon, MJ; Schutze, GE; Smith, C; Walter, E; Martin, JM; Edwards, KA; Wald, ER ...
Published in: Antimicrob Agents Chemother
June 2005

In vitro susceptibility testing of 2,797 group A streptococcus (GAS) isolates demonstrated that telithromycin was fully active against all macrolide-susceptible strains and among 80 of 115 macrolide-resistant GAS expressing the M phenotype. Telithromycin resistance was identified in 2 of 45 strains expressing the inducible macrolide-lincosamide-streptogramin B phenotype and four of nine isolates expressing the constitutive macrolide-lincosamide-streptogramin B resistance phenotype.

Duke Scholars

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

June 2005

Volume

49

Issue

6

Start / End Page

2487 / 2489

Location

United States

Related Subject Headings

  • United States
  • Streptococcus pyogenes
  • Pharynx
  • Microbiology
  • Microbial Sensitivity Tests
  • Macrolides
  • Ketolides
  • Humans
  • Drug Resistance, Bacterial
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Green, M., Allen, C., Bradley, J., Dashefsky, B., Gilsdorf, J. R., Marcon, M. J., … Wald, E. R. (2005). In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother, 49(6), 2487–2489. https://doi.org/10.1128/AAC.49.6.2487-2489.2005
Green, Michael, Coburn Allen, John Bradley, Barry Dashefsky, Janet R. Gilsdorf, Mario J. Marcon, Gordon E. Schutze, et al. “In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.Antimicrob Agents Chemother 49, no. 6 (June 2005): 2487–89. https://doi.org/10.1128/AAC.49.6.2487-2489.2005.
Green M, Allen C, Bradley J, Dashefsky B, Gilsdorf JR, Marcon MJ, et al. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother. 2005 Jun;49(6):2487–9.
Green, Michael, et al. “In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.Antimicrob Agents Chemother, vol. 49, no. 6, June 2005, pp. 2487–89. Pubmed, doi:10.1128/AAC.49.6.2487-2489.2005.
Green M, Allen C, Bradley J, Dashefsky B, Gilsdorf JR, Marcon MJ, Schutze GE, Smith C, Walter E, Martin JM, Edwards KA, Barbadora KA, Rumbaugh RM, Wald ER. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother. 2005 Jun;49(6):2487–2489.

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

June 2005

Volume

49

Issue

6

Start / End Page

2487 / 2489

Location

United States

Related Subject Headings

  • United States
  • Streptococcus pyogenes
  • Pharynx
  • Microbiology
  • Microbial Sensitivity Tests
  • Macrolides
  • Ketolides
  • Humans
  • Drug Resistance, Bacterial
  • Anti-Bacterial Agents